Ryzodeg Penfil 3Ml (5s) contain insulin degludec and liraglutide (GLP-1 agonist) for type 2 diabetes as prescribed. Administer as directed; usually once daily. Prescription only.
Purpose
Treatment of type 2 diabetes when prescribed.
Ingredients
Insulin degludec, liraglutide; 3ml.
Warnings
Prescription only. For injection only. Do not share pen.
Side Effects
Hypoglycaemia, GI upset possible. Report severe abdominal pain or allergic reaction.
Storage Instructions
Store as per pack. Refrigerate before first use. Keep out of reach of children.
| Brand | Novo Nordisk Pharmaceuticals |
|---|---|
| Status | Active |
Customer reviews
Loading reviews…